These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 25529395)

  • 1. Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.
    Alan M; Grolimund E; Kutz A; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
    J Intern Med; 2015 Aug; 278(2):174-84. PubMed ID: 25529395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].
    Chen Y; Li C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department].
    Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Sicilia-Bravo I; Palomo-de Los Reyes MJ; Cabezas-Martínez A; Laín-Terés N; Estebaran-Martín J; Lozano-Ancín A; Cuena-Boy R
    Enferm Infecc Microbiol Clin; 2014 Apr; 32(4):225-35. PubMed ID: 24182623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
    Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
    Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.
    Bello S; Fandos S; Lasierra AB; Mincholé E; Panadero C; Simon AL; Gavin O; De Pablo F; Menendez R; Torres A
    Respir Med; 2015 Sep; 109(9):1193-206. PubMed ID: 26205553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
    Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B
    Crit Care; 2006; 10(3):R96. PubMed ID: 16805922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.
    Legramante JM; Mastropasqua M; Susi B; Porzio O; Mazza M; Miranda Agrippino G; D Agostini C; Brandi A; Giovagnoli G; Di Lecce VN; Bernardini S; Minieri M
    PLoS One; 2017; 12(11):e0187702. PubMed ID: 29161297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting mortality among older adults hospitalized for community-acquired pneumonia: an enhanced confusion, urea, respiratory rate and blood pressure score compared with pneumonia severity index.
    Abisheganaden J; Ding YY; Chong WF; Heng BH; Lim TK
    Respirology; 2012 Aug; 17(6):969-75. PubMed ID: 22574694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.
    Aujesky D; Auble TE; Yealy DM; Stone RA; Obrosky DS; Meehan TP; Graff LG; Fine JM; Fine MJ
    Am J Med; 2005 Apr; 118(4):384-92. PubMed ID: 15808136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of plasma human β-defensin 2 level on short-term clinical outcomes in patients with community-acquired pneumonia: a preliminary study.
    Liu S; He LR; Wang W; Wang GH; He ZY
    Respir Care; 2013 Apr; 58(4):655-61. PubMed ID: 23051183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory responses predict long-term mortality risk in community-acquired pneumonia.
    Guertler C; Wirz B; Christ-Crain M; Zimmerli W; Mueller B; Schuetz P
    Eur Respir J; 2011 Jun; 37(6):1439-46. PubMed ID: 21071473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores.
    Valencia M; Badia JR; Cavalcanti M; Ferrer M; Agustí C; Angrill J; García E; Mensa J; Niederman MS; Torres A
    Chest; 2007 Aug; 132(2):515-22. PubMed ID: 17505026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
    Krüger S; Ewig S; Kunde J; Hartmann O; Suttorp N; Welte T;
    Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
    Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
    Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.
    Yandiola PPE; Capelastegui A; Quintana J; Diez R; Gorordo I; Bilbao A; Zalacain R; Menendez R; Torres A
    Chest; 2009 Jun; 135(6):1572-1579. PubMed ID: 19141524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CCERW: a new rule to predict treatment failure in patients with community-acquired pneumonia in middle aged and elderly people].
    Li JS; Li SY; Yu XQ; Sun ZK; Zhang W; Jia XH; Zheng SP; Wang MH; Wang HF
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jan; 23(1):10-7. PubMed ID: 21251359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of pneumonia severity index and CURB-65 severity scoring systems in community acquired pneumonia in an Indian setting.
    Shah BA; Ahmed W; Dhobi GN; Shah NN; Khursheed SQ; Haq I
    Indian J Chest Dis Allied Sci; 2010; 52(1):9-17. PubMed ID: 20364609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.
    Bello S; Lasierra AB; Mincholé E; Fandos S; Ruiz MA; Vera E; de Pablo F; Ferrer M; Menendez R; Torres A
    Eur Respir J; 2012 May; 39(5):1144-55. PubMed ID: 22075489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective comparison of severity scores for predicting mortality in community-acquired pneumonia.
    Luque S; Gea J; Saballs P; Ferrández O; Berenguer N; Grau S
    Rev Esp Quimioter; 2012 Jun; 25(2):147-54. PubMed ID: 22707104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.